Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 1Hemorrhage 1

Interventions

Cyclophosphamide 222pembrolizumab 199Carboplatin 173Cisplatin 168Gemcitabine 167Paclitaxel 154Docetaxel 140Rituximab 137Radiotherapy 137Bevacizumab 137Nivolumab 126Dexamethasone 126Capecitabine 103fludarabine 102Pemetrexed 92fludarabine phosphate 91Fluorouracil 91Doxorubicin 85Oxaliplatin 79Etoposide 77Cytarabine 77Bortezomib 76Erlotinib Hydrochloride 74Leucovorin 72Filgrastim 68Lenalidomide 67Calcium Dobesilate 66Irinotecan 65atezolizumab 63Radiation 61

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Has results × Misoprostol × Clear all
NCT02209545 2023-09-07

Misoprostol for Reduction of Blood Loss During Fibroid Surgery

Northwestern University

Phase 4 Terminated
47 enrolled 4 charts

Hemorrhage, Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡